Interaction of p-benzoquinone with hemoglobin in smoker’s blood causes alteration of structure and loss of oxygen binding capacity  by Ghosh, Arunava et al.
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a  b  s  t  r  a  c  t
Cigarette  smoke  (CS)  is  an important  source  of morbidity  and  early  mortality  worldwide.  Besides  causing
various life-threatening  diseases,  CS  is also  known  to cause  hypoxia.  Chronic  hypoxia  would  induce
early  aging  and  premature  death.  Continuation  of  smoking  during  pregnancy  is a known  risk  for  the
unborn  child.  Although  carbon  monoxide  (CO)  is  considered  to  be  a  cause  of  hypoxia,  the effect  of other
component(s)  of  CS  on hypoxia  is not  known.  Here  we  show  by immunoblots  and  mass  spectra  analyses
that  in  smoker’s  blood  p-benzoquinone  (p-BQ)  derived  from  CS forms  covalent  adducts  with  cysteine
93  residues  in both  the    chains  of  hemoglobin  (Hb)  producing  Hb-p-BQ  adducts.  UV–vis  spectra  and
CD  spectra  analyses  show  that  upon  complexation  with  p-BQ  the  structure  of  Hb  is  altered.  Compared
to  nonsmoker’s  Hb,  the  content  of  -helix  decreased  signiﬁcantly  in smoker’s  Hb  (p =  0.0224).  p-BQ alsoxygen binding capacity
ORM-3
tricarbonylchloro(glycinato)ruthenium(II)]
induces  aggregation  of  smoker’s  Hb  as demonstrated  by  SDS-PAGE,  dynamic  light  scattering  and  atomic
force  microscopy.  Alteration  of  Hb  structure  in  smoker’s  blood  is  accompanied  by reduced  oxygen  binding
capacity.  Our  results  provide  the  ﬁrst  proof  that  p-BQ is a cause  of hypoxia  in  smokers.  We  also  show
that  although  both  p-BQ  and  CO  are  responsible  for causing  hypoxia  in  smokers,  exposure  to  CO  further
affects  the  function  over  and  above  that produced  by  Hb-p-BQ  adduct.
© 2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
Cigarette smoking has been identiﬁed as the most important
ource of morbidity and mortality worldwide. The Centers for Dis-
ase Control (CDC) estimate that smoking will result in death or
isability for half of all people who continue to smoke [1]. Gen-
rally the life expectancy of smokers is nearly 14 years less than
onsmokers [2–5]. Apart from causing the various life-threatening
iseases such as cancer of the lung and other organs, chronic
bstructive pulmonary disease (COPD) and cardiovascular disease
CVD), cigarette smoke (CS) is also known to produce hypoxia [6,7].
n states of oxygen deﬁciency, the cells, tissues and the body as
 whole are deprived of vital energy. Chronic hypoxia may  be a
ause of early aging, morbidity and premature death. Moreover,
S-related degenerative diseases such as cancer, COPD and CVD are
ikely to be further complicated by hypoxia resulting in shortening
∗ Corresponding author at: Department of Biotechnology and Dr. B. C. Guha Centre
or Genetic Engineering & Biotechnology, Calcutta University College of Science, 35,
allygunge Circular Road, Kolkata 700019, India. Fax: +91 33 24614849.
E-mail address: ibc123@gmail.com (I.B. Chatterjee).
ttp://dx.doi.org/10.1016/j.toxrep.2016.02.001
214-7500/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
of life-span. Also, smoking during pregnancy causes reduced avail-
ability of oxygenated blood to the fetus resulting in intrauterine
hypoxia and various risks for the unborn child [8–11]. However, the
molecular mechanisms of cigarette smoke (CS)-induced hypoxia
are not clear.
Cigarette smoke (CS) is a complex mixture of harmful chemi-
cals, including long-lived semiquinones and carbon monoxide (CO)
[12,13]. CO forms carboxyhemoglobin (COHb) in smoker’s blood
and this may  be one of the mechanisms of hypoxia in heavy smokers
[13]. However, the formation of COHb is a reversible process. The
half-life of COHb of CO-poisoned patients treated with 100% oxy-
gen at atmospheric pressure is about 74 ± 25 min [14]. Earlier we
had shown that irrespective of the source, CS contains substantial
amounts (100–200 g/cigarette) of p-benzosemiquinone (p-BSQ)
[15,16]. In the smoker’s lung, p-BSQ is converted to p-benzoquinone
(p-BQ), which is a strong arylating agent [17,18]. p-BQ produced in
the smoker’s lungs gets into the blood stream and forms covalent
adducts with -amino groups of lysine residues of human serum
albumin (HSA) [18]. This results in alteration of structure and ligand
binding capacity of HSA [18]. Being a hydrophobic compound, p-BQ
readily enters the cell [19]. We  conceive that in the smoker’s blood,
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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-BQ would enter into the red blood cells (RBC) and form covalent
dduct with hemoglobin (Hb), which might result in alteration of
ts structure. The structure of Hb is so delicately balanced that small
tructural change such as modiﬁcations of internally located amino
cid residues may  render it nonfunctional for carrying oxygen [20].
e further envisage that the associated structural changes, if any,
ight alter the oxygen binding capacity, resulting in reduced oxy-
en delivery to the tissues leading to hypoxia. Since smokers are
lso exposed to CO [13], we were interested to see the interaction
f CO with p-BQ on oxy-Hb.
. Materials and methods
.1. Materials
Human Hb was purchased from Sigma (H7379) and used with-
ut further puriﬁcation. p-Benzoquinone (p-BQ) was  obtained from
imedia (RM-489) and freshly crystallized from n-hexane before
se. All other reagents used were of analytical grade. Afﬁnity puri-
ed polyclonal antibody to p-BQ raised in rabbit after immunization
ith p-BQ-bovine serum conjugate was supplied by Abexome Bio-
ciences, Bangalore, India. LC/MS- grade solvents, acetonitrile and
ormic acid were purchased from Fluka. RapiGestTM. Sodium iodide
NaI), polyethylene glycol (PEG) mix  and Glu-ﬁbrino peptide B
GFP) were obtained from Waters (Milford, MA,  USA). Trypsin was
urchased from Sigma–Aldrich (St. Louis, MO,  USA). Ammonium
icarbonate and ammonium acetate were purchased from Merck
India). All other reagents used were of analytical grade.
.2. Ethics statement
The collection of human blood and subsequent experiments
ere approved by the Institutional Bioethics Committee for ani-
al  and human research studies, University of Calcutta, following
he Code of Ethics of the World Medical Association (Declaration
f Helsinki) for experiments involving humans. Written consents
ere obtained prior to collection of blood.
.3. Preparation of Hb-p-BQ adduct
Hemoglobin was incubated with p-BQ in deﬁnite molar ratios
1:1, 1:2, 1:10, 1:20, 1:50) in 20 mM potassium phosphate buffer
pH 7.4) for two hours at 37 ◦C in the dark. The reaction mixture
as dialyzed overnight at 4 ◦C to remove excess/free p-BQ and
ydroquinone formed as a reaction product. The stock solution was
iluted and used for subsequent experiments.
.4. Isolation of hemoglobin from of human blood
Red blood cell (RBC) was isolated from whole blood using Ficoll-
aqueTM PLUS reagent (Amersham Biosciences) following standard
rotocol and the pellet was  washed with phosphate buffered saline
PBS) thrice. RBC was lysed by adding equal volume milliQ water to
he pellet. The resulting solution was centrifuged at 20,000 × g for
5 min  at 4 ◦C and the supernatant puriﬁed through PD-10 Desalt-
ng Column followed by Centricon centrifugation using 30 k Da
embrane and the puriﬁed Hb was used for subsequent experi-
ents.
For mass spectra analysis, Hb was isolated following the method
escribed elsewhere [21]. Brieﬂy, venus blood from smokers, col-
ected in EDTA vial, was centrifuged at 1248 × g for 10 min  at 25 ◦C.
he obtained packed cells was washed with 0.9% NaCl thrice and
hen lysed with eight volumes of ice cold distilled water. The
emolysate was centrifuged at 12,880 × g for 10 min  at 4 ◦C to
emove the erythrocyte membranes. The Hb solution was thenorts 3 (2016) 295–305
lyophilized, stored at −20 ◦C and used for mass spectroscopic anal-
ysis when needed.
2.5. Spectrophotometry of Hb-p-BQ adduct
The stock Hb solution prepared as described above was  diluted
to desired concentration and the absorbance was measured from
200 to 700 nm in a Shimadzu UV-2540 spectrophotometer. For
time-dependent measurement of Hb-p-BQ interaction, Hb was
incubated with p-BQ at a molar ratio of 1:50.
2.6. Mass spectrometric analysis of Hb-p-BQ adduct A. Intact
protein analysis
Samples were prepared and dialyzed overnight against 10 mM
ammonium acetate, pH 7.4. Immediately before the mass spectro-
scopic analysis, the lysate was  diluted to a concentration of 25 M
in 10 mM ammonium acetate, pH 7.4. Using gold coated borosil-
icate capillaries, the sample was  infused into nano-ESI source of
Synapt HDMS mass spectrometer (Waters, Manchester, UK). Data
were acquired in positive ion mode with a capillary voltage of
1.9 kV in the m/z range 650–5000. TOF analyzer was calibrated
using cesium iodide (2 mg/ml) in 50% aqueous 2-propanol. The
instrument acquisition parameters were adjusted to obtain opti-
mal  signals. The sampling and extraction cone voltages were set to
100 V and 2 V respectively. Source temperature was maintained at
37 ◦C and the gas ﬂow was set at 1.5 ml/min. The backing pressure
was increased to 5.9 m bar for better transmission of large protein
assemblies aided by collisional cooling. Data were acquired and
processed with MassLynx v4.1 software (Waters, UK).
2.7. Globin chain analysis
2 g of hemolysate protein was injected through a C18 RP
analytical column (ZORBAX Eclipse, 150 mm  × 4.6 mm,  3.5 m)  at
room temperature. Globin chains were eluted using a linear gradi-
ent of 2% increase in acetonitrile per minute containing 0.1% acetic
acid at a ﬂow rate of 0.2 ml/min and the mass analysis was per-
formed on Synapt HDMS with electrospray ionization (ESI) source
(Waters). The data were acquired in positive ion ‘V’ mode over
the range of 650–1500 m/z, with a capillary voltage of 3 kV using
a source temperature of 120 ◦C and desolvation gas temperature
of 350 ◦C. The mass calibration was  done using NaI. The mass
spectrum was  smoothed, baseline subtracted, and subsequently
deconvoluted using MaxEnt1 software. Since the charge state dis-
tributions of -globin chain and its adducts were observed to be
identical in mass spectra, the respective signal intensities of differ-
ent molecular ions were correlated with their relative abundance.
The most intense signals of the observed protonated populations,
namely, , glycated-, glutathionylated- and pBQ adduct of the -
globin chain were found to be distributed across the charge states
from 11 to 19. Thus the quantiﬁcation of each population of -
globin adducts was  calculated as follows:
pBQ −  adduct of hemoglobin%
= pBQ adduct of  × 100
( + Hb − gly + Hb − GS + pBQ adduct of ) (1)
Hb − gly × 100
Hb − gly% =
( + Hb − gly + Hb − GS + pBQ adduct of ) (2)
Hb − GS% = Hb − GS × 100
( + Hb − gly + Hb − GS + pBQ adduct of ) (3)
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.7.1. Proteolytic digestion
Hb modiﬁed with p-BQ in the molar ration 1:2 was digested
ith proteolytic enzyme trypsin. Modiﬁed Hb was denatured by
ncubating 10 g of protein with 1 l of 0.2% RapiGestTM in 50 mM
H4HCO3 (pH 7.8) at 80 ◦C for 15 min. Following denaturation, pro-
eolytic digestion was performed at 37 ◦C overnight using trypsin
s proteolytic enzyme, at a ratio trypsin:hemoglobin 1:10 (w/w).
o break down RapiGestTM, the digested sample was  acidiﬁed with
 l of formic acid (FA) and incubated at 37 ◦C for 90 min. It was then
entrifuged at 6000 rpm for 20 min  and supernatant was  taken for
ass spectrometry based proteomics analysis.
.7.2. nLC/ESI-MS
Digested protein (100 fmol) was loaded onto a nano Acquity
PLC 1.7 m BEH130C18 column (250 mm × 75 m)  at 35 ◦C. Pep-
ides were eluted with a gradient of 3–40% of solvent B over 60 min
sing a ﬂow rate of 300 nl/min, where solvents A and B consisted of
ater and acetonitrile with 0.1% FA, respectively. The eluted pep-
ides were analyzed in Synapt HDMS (Waters, UK) coupled to nano
cquity UPLC. The data were acquired in the mass range 50–1600
/z using the MSE mode of acquisition. Reference compound GFP
as continuously infused through lockspray and scanned every
5 s. MS  calibration was done with GFP. The data was  analysed using
LGS 2.5 software.
.8. Circular dichroism (CD) analysis
Far UV-CD spectra of Hb and Hb-p-BQ adduct was recorded
n a Jasco J720 spectropolarimeter by scanning reaction mix-
ures from 190 to 250 nm using 1 mm path length cuvette.
ean residual ellipticity (MRE) was calculated using the formula,
W = [Observed()]/[10 × Cp × n × l] in deg cm2 dmol−1, where  is
he observed ellipticity in millidegree, MW is the molecular weight
n k Da, Cp is the molar concentration, n is the number of amino
cids and l is the path length in cm.  The -helix percentage was
alculated using MRE  value at 222 nm according to the formula
(MRE-2340)/30300] × 100 [22].
.9. Dynamic light scattering (DLS)
Nano-ZS (Malvern) instrument (5 mW HeNe laser , 632 nm)
as used for photon correlation spectroscopy. The samples
0.25 mg/ml) were poured into a DTS0112 low-volume disposable
izing cuvette of 1.5 ml  (path length 1 cm)  after passing through
 0.22 m ﬁlter. Using the DTS software supplied with the instru-
ent, the operating procedure was programmed to record average
f 30 runs, each run being averaged for 15 s. A particular Stokes
adius (Rh) was computed in each case and the result ultimately
resented as the size distribution by numbers of Rh.
.10. Atomic force microscopy (AFM)
Human Hb (Sigma), Hb-p-BQ adduct prepared from Hb and also
b isolated from blood (smokers/nonsmokers) were dissolved in
0 mM ammonium bicarbonate buffer (pH 7.4) (10 l of 1 M solu-
ion) and deposited onto freshly cleaved muscovite Ruby mica sheet
ASTM V1 Grade Ruby Mica from MICAFAB, Chennai) and dried
or 5–10 min  at room temperature. Tapping mode AFM was per-
ormed using a Pico plus 5500 AFM (Agilent Technologies USA) with
 piezoscanner of maximum range up to 9 m.  Micro fabricated
ilicon cantilevers of 225 m in length with a nominal spring force
onstant of 21–98 N/m were used from Nano sensors. Cantilever
scillation frequency of 275.1 kHz was tuned into resonance fre-
uency. The images (256 by 256 pixels) were captured with a scan
ize between 0.5 and 3 m at the scan speed rate of 0.499 lines/s or
.474 m/s. Images were processed using Pico view 1.10.1 (9995)orts 3 (2016) 295–305 297
software (Agilent Technologies, USA). Length, height and width of
Hb and Hb-p-BQ adducts were measured manually using Pico view
1.10.1 (9995) software.
2.11. Assay of oxygen uptake by Hb
Analysis of oxygen uptake by Hb (10 nmoles of Hb in 2 ml  of
MIli-Q water), isolated from smokers and nonsmokers as described
above, was carried out using Gilson Oxygraph (Gilson Medical Elec-
tronics, Middleton, Wisconsin). Parallel experiments were carried
out using pure human Hb (Sigma–Aldrich) before and after conju-
gation with p-BQ.
2.12. Interaction of CORM-3 (carbon monoxide releasing
molecule) with p-BQ on oxy-Hb
The release of CO from CORM-3 [tricar-
bonylchloro(glycinato)ruthenium(II)] was  assessed
spectrophotometrically by measuring conversion of oxy-Hb
to carboxyhemoglobin (HbCO). Hb (5 mM)  isolated from non-
smoker’s blood was  treated with dithionite (0.1%) to reduce any
MetHb present followed by vortexing in air to produce oxy-Hb
according to the method described elsewhere [23]. To study the
effect of CORM-3 on oxy-Hb, 10 ml  aliquots from a stock solution of
CORM-3 (50 mM)  were added to a cuvette containing 5 mM oxy-Hb
in potassium phosphate buffer, pH 7.4 and absorption spectrum
was recorded in triplicate in a spectrophotometer (Shimadzu
UV-2540). Successive additions of CORM-3 were made to reach
ﬁnal CORM-3 concentrations of 0.5, 1.0, 1.5, 2.0 and 4.0 mM.  The
amount of HbCO formed was calculated from the difference of soret
peak of human oxy-Hb at 415 nm (eHbO2415 nm = 128 mM−1 cm−1
[24], before and after addition of CORM-3 following the method of
Antonini and Brunori [25].
To study the effect of p-BQ on CORM-3 treated oxy-Hb, 2 mM
CORM-3 (ﬁnal concentration) was added to a cuvette contain-
ing 5 mM oxy-Hb in potassium phosphate buffer, pH 7.4 and
absorbance was recorded after 5 min. Then 10.8 g p-BQ was added
to the cuvette to obtain Hb:p-BQ in a molar ratio of 1:20 and
absorbance spectrum was  recorded after 5 min.The experiment
was repeated using 4.0 mM CORM-3 (ﬁnal concentration).
The effect of CORM-3 on Hb-p-BQ conjugate was  studied by
adding different concentrations of CORM-3 (ﬁnal, 0.5, 1.0, 2.0 and
4.0 mM,  respectively) to 5 mM oxy-Hb:p-BQ (in molar ratio 1:20) in
potassium phosphate buffer, pH 7.4. Absorption spectrum for each
CORM-3 ﬁnal concentration was  recorded in triplicate. The effect
of CORM-3 was calculated on the basis of difference of absorbance
at soret peak of p-BQ-oxy-Hb conjugate at 413 nm following the
method of published elsewhere [25].
2.13. Statistical calculation
All values are expressed as mean ± SD. Statistical signiﬁcance
was carried out using one way ANOVA. The p-values were calcu-
lated using appropriate F-tests. Difference with p-values <0.05 was
considered signiﬁcant.
3. Results
3.1. Identiﬁcation and characterization of Hb-p-BQ adduct in
smoker’s bloodUsing antibody against p-BQ, here we show by immunoblot
that smoker’s blood contains Hb-p-BQ adduct (Fig. 1A). Quantita-
tion of immunoblots (Fig. 1B) shows that moderate smokers (≈15
cigarettes/day for 15–20 years) have signiﬁcantly more (p = 0.0000)
298 A. Ghosh et al. / Toxicology Rep
Fig. 1. Representative immunoblots of pure Hb and Hb isolated from blood of smok-
ers  (Sm Hb) and nonsmokers (Ns Hb) (male, 45–55 years) showing Hb-p-BQ adducts.
(A) Hb, pure Hb; NS Hb, Hb isolated from blood of nonsmokers; Sm Hb, Hb isolated
from smokers. Sm Hb 4, mild smoker (≈10 cigarettes/day for 15–20 years); Sm Hb
5,  6, moderate smokers (≈15 cigarettes/day for 15–20 years). (B) Quantitation of
immunoblots using NIH image J. * indicates signiﬁcant increase (p = 0.0000) in Hb-
p-BQ adduct in blood of moderate smokers compared to mild smokers. Fifteen g
protein was  loaded in each lane.Bottom panel, ponceau S staining as the loading
control.
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nig. 2. The best ﬁt line indicating increase in relative abundance of p-BQ adduct of
emoglobin in vivo with increase in the number of cigarettes smoked per day.
b-p-BQ adduct than that of mild smokers (≈10 cigarettes/day for
5–20 years).
We  analyzed Hb and its adducts present in smoker’s blood using
C/ESI-MS platform. Mass analyses of different globin polypep-
ide chains indicated the presence of three major adducts of
-globin chain, namely, glutathionylated  (16172 Da), glycated 
16028 Da) and p-BQ adduct of  chain (15973 Da) (Supplementary
ig. 1). There was no p-BQ adduct observed in -globin chain.
The relative abundance of p-BQ adduct of -globin chain was
alculated in the four smoker’s blood samples as described in meth-
ds. Although there were variations in the age and years of smoking
cross different subjects, we attempted to correlate the number of
igarettes smoked per day by each individual with quantiﬁed values
f p-BQ adduct of -globin chain. An increasing trend in the relative
bundance of p-BQ adduct was observed with the increase in the
umber of cigarettes smoked per day (Fig. 2). The p-BQ adduct oforts 3 (2016) 295–305
the -globin chain in smokers blood was  calculated as mentioned
under Materials and Methods. The percentages of p-BQ adduct was
found to be 9.22%, 12.05%, 14.93%, 14.37% for inviduals who smoked
4, 11, 15 and 20 cigarettes per day respectively (Fig. 2).
On incubation of nonsmoker’s human Hb with p-BQ in vitro at
physiological pH and temperature showed the formation of a cova-
lent adduct in the hemoglobin tetramer. Fig. 3, panel A shows the
mass spectra of non-covalently bound four globin chains alongwith
their respective heme units. The appearance of different peaks with
m/z (+z) at 3404.3 (+19), 3593.5 (+18) and 3804.8 (+17) shows the
presence of a molecular ion of mass 64665 Da. The calculated stoi-
chiometry obtained from the masss analysis of Hb adduct indicates
the presence of two p-BQ moieties per Hb tetramer [(h)2(pBQh)2].
Additionally, we observed the glutathionylated adduct of the afore-
mentioned molecular ion having low intensity at 64970 Da. Fig. 3
panel B shows the mass spectra of p-BQ adduct of the tetramer
[(h)2(pBQh)2] in different globin chains synthesized in vitro. Fig. 3
panel C shows the following masses of the different globin chains:
 (15126 Da),  (15867 Da) and pBQ (15972 Da). The mass analyses
of both tetramer and monomer indicated that in vitro modiﬁcation
of Hb with p-BQ results in incorporation of one p-BQ moiety per -
globin chain. The globin chain did not undergo any modiﬁcation.
Bottom-up proteomics approach was used to identify the site
of modiﬁcation on the -globin chain. The p-BQ adduct of Hb syn-
thesized in vitro was subjected to proteolysis using trypsin as the
proteolytic enzyme. The tryptic digest was  analysed using nano
LC-MSE method and the obtained data was processed using PLGS
2.5 software and searched against normal human Hb database
with p-BQ as modifying agent. The proteomics analysis iden-
tiﬁed the peptide fragment (charge—4+, precursor rms  mass
error—17.44 ppm, PLGS score—7.96) consisting of residues 85–102
of -globin chain carrying a p-BQ moiety covalently bonded to
Cys-93.
3.2. Spectrophotometric analysis of Hb-p-BQ adduct
The formation of Hb-p-BQ adduct was monitored by changes
in the absorption spectrum at different molar concentrations of
Hb:p-BQ and also in a time-dependent manner. Pure Hb spectrum
exhibited two  peaks, one at 414 nm corresponding to the Soret
band and another peak around 273 nm characterizing the aromatic
amino acids present in the Hb molecule. Hb was incubated with p-
BQ at different molar ratios and dialyzed overnight to eliminate any
excess/free p-BQ and hydroquinone formed as a reaction product.
Examination of the reaction mixtures revealed that compared to
pure Hb, there was a decrease in the Soret band of Hb-p-BQ adduct.
The decrease was about 1.5%, 10.34%, 15.50% and 19.38% in Hb-
pBQ adduct produced in the molar ratios of 1:1, 1:10, 1:20 and
1:50, respectively. This alteration was accompanied by an increase
in absorbance at 350 nm corresponding to the formation of p-BQ
adduct as reported earlier [18] (Fig. 4). Time-dependent interac-
tion between Hb with p-BQ at molar ratio of 1:50 revealed similar
reduction in the Soret band. The absorbance reduced signiﬁcantly
to 26.18% (p = 0.0000, n = 3) after two hr incubation with consequent
increase in absorbance at 350 nm indicating augmented forma-
tion of p-BQ adduct (Fig. 5). Fig. 6 shows that there is a signiﬁcant
decrease of Soret band of about 16.6% (p = 0.0000) of smokers Hb
(0.346 ± 0.001, n = 6) compared to nonsmoker’s Hb (0.425 ± 0.001,
n = 6).
3.3. Alteration in the secondary structure of Hb after interaction
with p-BQThe alteration of secondary structure was  investigated using far
UV-CD. Spectropolarimetric analysis of pure Hb elucidated negative
ellipticity at 208 nm and 222 nm indicating a primarily -helical
A. Ghosh et al. / Toxicology Reports 3 (2016) 295–305 299
Fig. 3. (A) Mass spectrum of non-covalently bound four globin chains alongwith their respective heme units. (B) Mass spectrum of the different globin chains present in p-BQ
adduct of the tetramer [(h)2(pBQh)2] synthesized in vitro. (C) Deconvoluted mass spectrum of the different globin chains:  (15126 Da),  (15867 Da) and pBQ (15973 Da).
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Fig. 5. Absorption spectra of Hb and HB-p-BQ adducts at molar ratios of Hb:p-BQ
(1:50) at different time intervals of incubation showing gradual decrease of Soretig. 4. Absorption spectra of Hb and HB-p-BQ adducts at different molar ratios of
b:p-BQ (1:1–1:50) showing gradual decrease of Soret band at 414 nm accompanied
y  increase in absorption at 350 nm indicating formation of Hb-p-BQ adduct.
onformation. In the Hb-p-BQ adduct prepared at molar ratio of
:50, the Hb molecule showed an overall decreased ellipticity and
he percentage of -helix content decreased signiﬁcantly from
3.79 ± 0.7 to 72.4 ± 1.6 (p = 0000) (Fig. 7). The Hb isolated from
moker’s blood also showed a decreased ellipticity indicating loss
f secondary structure compared to the Hb from nonsmoker’s
lood (Fig. 8). The content of -helix (73.92% ± 4.8) decreased
igniﬁcantly (p = 0.0224, n = 6) in smoker’s Hb compared to that
81.88% ± 5.40) of nonsmoker’s Hb.band at 414 nm accompanied by increase in absorption at 350 nm, indicating for-
mation of Hb-p-BQ adduct.
3.4. Aggregation of Hb molecules after interaction with p-BQ
p-BQ is known to form cross-links and aggregation of proteins
[26,27]. Using SDS-PAGE we  demonstrated that interaction of Hb
with p-BQ in concentration-dependent and time-dependent man-
ner produced Hb aggregation (Fig. 9A, B). Our results also show that
compared to nonsmoker’s Hb, smoker’s Hb contains aggregated Hb
(Fig. 9C).
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Fig. 6. Decrease in Soret band of Hb isolated from blood of moderate smokers com-
pared to nonsmokers.
Fig. 7. Far UV CD spectra of Hb and Hb-p-BQ adduct at a molar ratio of 1:50, showing
change in the secondary structure.
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smokers (≈10 cigarettes/day). In a different subset of four smokers,ig. 8. Representative far UV CD spectra of Hb isolated from blood of moderate
mokers compared to nonsmokers showing change in the secondary structure.
To investigate the change in the molecular radius of hemoglobin
fter conjugation with p-BQ, we employed dynamic light scattering
DLS) technique to quantify the size of the protein. The molecu-
ar radius of pure hemoglobin was 4.85 nm,  which was  in good
greement with the previously published result [28]. The increased
adius of Hb as measured by DLS showed continuous rising trend
ith increasing molar concentrations of p-BQ indicating probable
ormation of Hb aggregates after interaction with p-BQ. The calcu-
ated molecular radii were 6.5 nm,  11.7 nm,  18.2 nm and 24.4 nmorts 3 (2016) 295–305
for Hb-p-BQ adducts in the molar ratios of 1:1, 1:10, 1:20 and 1:50,
respectively (Fig. 10A). When the molecular size of Hb from non-
smokers’ blood and that of smokers was  compared, the smoker’s
Hb showed a radius of 18.4 ± 1.7 nm while that of nonsmoker,
6.8 ± 0.7 nm (Fig. 10B). The aggregation of Hb in smoker’s blood
was also conﬁrmed by atomic force microscopy (Fig. 11A, B).
3.5. Oxygen binding capacity of Hb-p-BQ adduct
The alteration of structure and aggregation of smoker’s Hb was
accompanied by loss of oxygen (O2) binding capacity. When the
O2 binding capacity of pure Hb (38.96 ± 1.4 nmol O2/10 nmol Hb)
was compared with that of Hb-p-BQ adducts prepared at differ-
ent molar concentrations of p-BQ, O2 uptake was gradually lost
in a concentration-dependent manner (Fig. 12A). The values were
36.6 ± 1.4 (p = 0.100), 24.7 ± 1.4 (p = 0.002), 14.3 ± 2.4 (p = 0.001)
and 8.8 ± 1.4 (p = 0.000) at Hb:p-BQ molar ratios of 1:1, 1:10,
1:20, 1:50, respectively (Fig. 12A). Fig. 12B further shows that
the oxygen uptake of smoker’s Hb (31.0 ± 1.1 nmoles of O2/10
nmoles Hb) is signiﬁcantly less (p = 0.0000) than nonsmoker’s Hb
(36.6 ± 1.4 nmolof O2/10 nmoles.
3.6. Interaction of CORM-3 with p-BQ on oxy-Hb
We  have shown in this paper that p-BQ derived from CS pro-
duces Hb-p-BQ adduct in smokers that is accompanied by alteration
of structure and function of Hb. It is also well established that smok-
ers are exposed to CO as revealed by the formation of HbCO [13].
We were therefore interested to see how CO affects p-BQ mod-
iﬁcation of oxy-Hb and vice versa. We  simultaneously exposed
oxy-Hb to CORM-3 (a water soluble CO releasing molecule) and
p-BQ, a situation supposed to be happening in vivo. Fig. 13A shows
that treatment of 5 M nonsmoker’s oxy-Hb with 0.5, 1.0, 1.5, 2.0
and 4.0 M CORM-3 produced 1.96 ± 0.28, 3.37 ± 0.14, 4.91 ± 0.28,
5.75 ± 0.28 and 9.12 ± 0.14 SD %HbCO, respectively. A cohort study
indicates that in chronic smokers the %HbCO may  vary from 6.02%
to 9.6 [13]. Fig. 13B shows that additions of 2.0 and 4.0 M CORM-
3 that produce 4.91 and 9.12%HbCO, respectively, cause signiﬁcant
decrease (p = 0.000) in the soret peak (415 nm)  of oxy-Hb. Under
the condition, addition of p-BQ to the incubation medium does not
further affect the soret band. Also, when CORM-3 was added to
oxy-Hb-p-BQ conjugate in the incubation medium, 2.0 and 4.0 M
CORM-3 produced signiﬁcant decrease (p = 0.002 and 0.001, respec-
tively) in soret band (413 nm)  (Fig. 11C). The results indicate that
CO affects the function of oxy-Hb in smokers over and above that
produced by p-BQ.
4. Discussion
In this paper we have demonstrated by immunoblot and
mass spectrometry that smoker’s blood contains Hb-p-BQ cova-
lent adducts with −SH groups of cysteine residues (Cys93) of the
-globin chain of Hb. Using UV–vis spectroscopy, CD, SDS, DLS and
AFM, we have also shown that formation of p-BQ adducts is accom-
panied by alteration of structure and aggregation of Hb, leading to
reduced oxygen binding capacity. Using CORM-3, a CO releasing
molecule, we have further shown that p-BQ affects the function of
oxy-Hb over and above that produced by CO.
Quantitation of immunoblots indicate that the content of Hb-
p-BQ adduct is signiﬁcantly greater (p = 0.000, n = 10) in moderate
smokers (15–20 cigarettes/day for 15–20 years) than that of mildmass spectrometry based relative quantiﬁcation of p-BQ adduct of
-globin chain showed the presence of increasing amount of the
adduct with increase in number of cigarettes smoked.
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Fig. 9. SDS-PAGE of pure Hb, Hb-p-BQ adducts and Hb isolated from nonsmokers (Ns) and smokers (Sm). (A) Pure Hb and Hb-p-BQ adducts at different molar ratios. (B)
Hb-p-BQ  adduct at molar ratio of 1:50 at different time points of incubation at 37 ◦C in 20 mM potassium phosphate buffer, pH 7.4. (C) Representative SDS-PAGE of Hb isolated
from  Ns and Sm.  Experiments were done with 6 samples each of Ns and Sm.  Loading of Hb in each lane was 50 g in A & B and 30 g in C in a 14% gel; stained with Coomasie
Brilliant Blue-R250. The upper portion of each lane shows aggregation of Hb. Details are given under Section 2.
Fig. 10. (A) DLS analysis of hemoglobin before and after reaction with different concentrations of p-BQ. a,b,c,d and e represent Hb-p-BQ adduct at molar ratio of 1:0, 1:1,
1:10,  1:20 and 1:50, respectively. (B) Representative picture of DLS analysis of hemoglobin extracted from blood of (a) nonsmoker and (b) moderate smokers.
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Fig. 11. (A) Atomic Force Micrographs of (a) Hb and (b) Hb-p-BQ adduct at a molar ratio of 1:50. (B) Representative Atomic Force Micrographs of Hb isolated from (a)
nonsmokers and (b) moderate smokers.
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Human adult hemoglobin is a tetrameric protein consisting of 
nd -globin chains in duplicate where -globin subunit has one
ysteine residue (Cys104) and -globin subunit has two cysteine
esidues (Cys93, Cys112). Among those three cysteine residues
Cys93 is 5-fold more accessible compared to Cys112, whereas
Cys104 is completely buried [29].
Mass analysis of in vitro p-BQ adduct of hemoglobin in its
etrameric form showed the presence of two p-BQ moieties per
etramer. Subsequent mass analysis of individual globin chains
evealed that in the in vitro adduct, a single modiﬁcation occurred
n each -globin chain with  subunit remaining unmodiﬁed. Pro-
eomics analysis of in vitro p-BQ adduct of hempglobin conﬁrmed
Cys93 is the site of modiﬁcation in Hb. This covalent modiﬁca-
ion probably perturbs the conformation of the molecule resulting
n disruption of some potential salt bridges at the 12 and 21
nterfaces. Far-UV CD analysis indicated that conjugation with p-, *indicates highly signiﬁcant (*p = 0.0002, **p = 0.0000) compared to pure Hb; (B)
mokers (Ns). *indicates highly signiﬁcant (p = 0.0000; n = 10; CI 95% Ns: 35.4–37.8;
BQ altered the secondary structure of smoker’s Hb. The content of
 helix decreased signiﬁcantly (p < 0.05).
Interaction of Hb with p-BQ not only produce covalent adduct
but also cross-linking and aggregation of Hb. SDS-PAGE analysis,
DLS studies as well as AFM indicate that p-BQ forms Hb aggregates
and that smoker’s blood contains aggregated Hb.
It is reported that p-BQ forms 1, 4 Michael adduct with thiol
groups of proteins [30]. Nucleophilic additions of p-BQ at two
different sites with the sulfhydryl groups of Cys93 of two  differ-
ent Hb molecules might lead to cross-linking between tetramers
and aggregation of Hb molecules in smoker’s blood. Alteration of
the structure of Hb along with aggregation could be the cause of
reduced uptake of oxygen by smoker’s Hb.Smoking during pregnancy can lead to a plethora of health risks
to both the mother and the fetus [8–11]. Smoking in pregnancy
accounts for an estimated 20–30% of low birth weight babies, up to
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Fig. 13. Interaction of CORM-3 (carbonmonoxide releasing molecule) with p-BQ on oxy-Hb. (A) Formation of %HbCO after addition of CORM-3 to oxy-Hb. Aliquots from a
stock  solution of CORM-3 (50 mM)  were added successively to 5 mM oxy-Hb isolated from nonsmoker’s blood to attain ﬁnal CORM-3 concentrations of 0.5 mM,  1.0 mM,
1.5  mM,  2.0 mM and 4.0 mM.  Absorbance were recorded in triplicate at 200–700 nm after 5 min  of each CORM-3 addition; %HbCO was  calculated as means ± SD. Details are
given  in Materials and Method Section. (B) Effect of p-BQ on CORM-3 treated oxy-Hb. Aliquots of CORM-3 were separately added to 5 mM oxy-Hb isolated from nonsmoker’s
blood  to attain ﬁnal CORM-3 concentrations of 2.0 mM and 4.0 mM,  respectively. Five min  after addition of CORM-3, %HbCO obtained from these two concentrations were
5.75%  ± 0.28 SD and 9.12% ± 0.14 SD, respectively. This was  followed by addition of p-BQ (10.8 mg)  to obtain Hb:p-BQ molar ratio of 1:20. Five min  after addition of p-BQ,
absorbance spectra were recorded in triplicate; * indicates signiﬁcant difference of soret peak (at 415 nm)  with respect to untreated oxyHb. Details are given in Section 2. (C)
Effect  of CORM-3 on oxy-Hb-p-BQ adduct. To 5 mM oxy-Hb-p-BQ adduct (in the molar ratio of 1:20) CORM-3 was added in aliquots form a stock solution of 50 mM to attain
ﬁnal  CORM-3 concentrations of 0.5 mM,  1.0 mM,  2.0 mM and 4.0 mM,  respectively. 5 min after addition of each CORM-3 concentration, absorbance spectra were recorded in
triplicate; * indicates signiﬁcant difference of soret peak (at 413 nm)  with respect to untreated oxy-Hb:p-BQ adduct. Details are given in Section 2.
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4% of preterm deliveries, and some 10% of all infant deaths. Even
pparently healthy, full-term babies of smokers have been found to
e born with narrowed airways and reduced lung function [10]. A
ecent study conducted in the United Kingdom found that smokers
ere ﬁve times more likely to develop pre-eclamsia [31].
It is well established that smokers are exposed to CO and a mech-
nism of hypoxia is formation of HbCO [13]. We  have shown in
his paper that another cause of hypoxia in smokers is formation
f Hb-p-BQ adduct. p-BQ binds with cysteine residues of Hb and
his binding is covalent and irreversible. On the other hand, the
inding of CO with Hb is reversible [13]. Nevertheless, the afﬁnity
etween Hb and CO is approximately 230 times stronger than the
fﬁnity between Hb and oxygen [32]. Hb binds to CO in preference
o oxygen, resulting in less release of oxygen in the tissues. We  have
hown that exposure of oxy-Hb-p-BQ to CORM (a carbon monoxide
eleasing molecule) results in signiﬁcant decrease in the soret band
f oxy-Hb-p-BQ. This would indicate that although both p-BQ and
O are responsible for causing hypoxia in smokers, exposure to CO
urther affects the function of Hb-p-BQ.
. Conclusions
In conclusion, we demonstrated that in smokers p-BQ derived
rom cigarette smoke forms covalent adducts with cysteine 93
esidues in both the  chains of Hb producing Hb-p-BQ adducts.
he formation of p-BQ adducts is accompanied by alteration of the
tructure and aggregation of Hb, leading to reduced oxygen binding
apacity. Our results provide the ﬁrst proof that p-BQ is a cause of
ypoxia in smokers.
onﬂict of interest
The authors declare that they do not have any conﬂict of interest.
ontributors
IBC conceived and designed major part of the experiments. RB
esigned part of the experiments on biophysical studies. AG per-
ormed a major part of the experiments. BR did some biophysical
tudies. SB did experiments on CORM studies and oxygen bind-
ng capacity. IBC, RB and AKM analyzed the data. Contributed
eagents/materials/analysis tools: IBC, AKM. Wrote the paper: IBC
nd AM. AM,  MM and AKM carried out the mass spectra analyses.
unding
This research was supported by the Juthika Research Founda-
ion, Krishna and Suhkamay Lahiri Cancer Research Foundation and
hulrenu Guha Research Fellowship of the University of Calcutta.
ransparency document
The Transparency document associated with this article can be
ound in the online version.
cknowledgments
We thank Latika Nagpal and Kaushik Bhar for their technical
ssistance.
ppendix A. Supplementary dataSupplementary data associated with this article can be found,
n the online version, at http://dx.doi.org/10.1016/j.toxrep.2016.02.
01.
[
[orts 3 (2016) 295–305
References
[1] CDC, The Health Consequence of Smoking: A Report of the Surgeon General,
US  Department of Health and Human Services, Atlanta, GA, 2004.
[2] ACS, Prevention and Early Detection. Guide to Quitting Smoking, American
Cancer Society, Atlanta, 2010 http://www.cancer.Org/Healthy/
Stayawayfromtobacco/Guidetoquittingsmoking/I.
[3]  USDHHS, 1989. Centers for Disease Control, Center for Chronic Disease
Prevention and Health Promotion, Ofﬁce on Smoking and Health Reducing
the Health Consequence of Smoking: 25 Years of Progress. A Report of the
Surgeon General; (1989). DHHS Publication (CDC) 89–8411 (1989).
[4]  USDHHS. Centers for Disease Control and Prevention : The health
consequence of smoking: a report of the Surgeon General. Atlanta, GA (2004).
[5] J.L. Fellows, A. Trosclair, National Center for Chronic Disease Prevention and
Health Promotion, CDC, Annual Smoking-Attributable Mortality, Years of
Potential Life Lost and Economic Costs-United States, 1995–1999., Morbidity
and Mortality Weekly Report, 51, (2002), 300–303.
[6] J.A. Jensen, W.H. Goodson, H.W. Hopf, T.K. Hunt, Cigarette smoking decreases
tissue oxygen, Arch. Surg. 126 (1991) (1991) 1131–1134.
[7] A. Afaqa, P.A. Montgomery, K. Scott, S.M. Blevins, T.L. Whitsetta, A.W.
Gardnerb, The effect of current cigarette smoking on calf muscle hemoglobin
oxygen saturation in patients with intermittent claudication, Vasc. Med. 12
(2007) 167–173.
[8] M.L. Socol, F.A. Manning, Y. Murata, M.L. Druzin, Maternal smoking causes
fetal hypoxia, Am.  J. Obstet. Gynecol. 142 (1990) 214–218.
[9] M.G. Bulterys, S. Greenland, J.F. Kraus, Chronic fetal hypoxia and sudden
infant death syndrome: interaction between maternal smoking and low
hematocrit during Pregnancy, Pediatrics 86 (1990) 535–540.
10] USDHHS. Centers for Disease Control and Prevention : The health
consequence of smoking: a report of the Surgeon General Atlanta, GA 2001.
11] M.  Prelog, Smoking and Reproduction, in Cigarette Smoke Toxicity: Linking
Individual Chemicals to Human Diseases, in: D. Bernhard (Ed.), Wiley-VCH
Verlag GmbH & CoKGaA, Weinheim, Austria, 2011, pp. 217–237.
12] W.A. Pryor, K. Stone, L.-Y. Zang, E. Bermudez, Fractionation of aqueous
cigarette tar extracts: fractions that contain the tar radical cause DNA
damage, Chem. Res. Toxicol. 1 (1998) (1998) 441–448.
13] S. Sen, C. Peltz, J. Beard, B. Zeno, Recurrent carbon monoxide poisoning from
cigarette smoking, Am.  J. Med. Sci. 340 (2010) 427–429.
14] L.K. Weaver, S. Howe, R. Hopkins, K.J. Chan, Carboxyhemoglobin half-life in
carbon monoxide-poisoned patients treated with 100% oxygen at
atmospheric pressure, Chest 117 (2000) 801–808.
15] I. B. Chatterjee, Process for the isolation of a major harmful oxidant from
cigarette smoke. US Patent (2005) No. 6929012.
16] N. Dey, A. Das, A. Ghosh, I.B. Chatterjee, Activated charcoal ﬁlter effectively
reduces p-benzosemiquinone from the mainstream cigarette smoke and
prevents emphysema, J. Biosci. 35 (2010) 217–230.
17] S. Banerjee, R. Chattopadhyay, A. Ghosh, H. Koley, K. Panda, S. Roy, D.
Chattopadhyay, I.B. Chatterjee, Cellular and molecular mechanisms of
cigarette smoke-induced lung damage and prevention by vitamin C, J.
Inﬂamm. (Lond.) 5 (2008) 21.
18] A. Ghosh, A. Choudhury, A. Das, N.S. Chatterjee, T. Das, R. Chowdhury, K.
Panda, R. Banerjee, I.B. Chatterjee, Cigarette smoke induces
p-benzoquinone-albumin adduct in blood serum: implications on structure
and ligand binding properties, Toxicology 292 (2012) 78–89.
19] N. Dey, D.J. Chattopadhyay, I.B. Chatterjee, Molecular mechanisms of cigarette
smoke induced proliferation of lung cells and prevention by vitamin C, J.
Oncol. (2011), Article ID 561862.
20] D. Voet, J.G. Voet, Biochemistry, 3rd ed., Wiley International ed., USA, 2004,
pp. 340.
21] R. Das, G. Mitra, B. Mathew, C. Ross, V. Bhat, A.K. Mandal, Automated analysis
of hemoglobin variants using nano LC–MS and customized databases, J.
Proteom. Res. 12 (2013) 3215–3222.
22] Y.H. Chen, J.T. Yang, H.M.  Martinez, Determination of the secondary structures
of proteins by circular dichroism and optical rotatory dispersion,
Biochemistry 11 (1972) 4120–4131.
23] S. Chlopicki, R. Olszanecki, E. Marcinkiewicz, M.  Lomnicka, R. Motterlini,
Carbon monoxide released by CORM-3 inhibits human platelets by a
mechanism independent of soluble guanylate cyclase, Cardiovasc. Res. 71
(2006) 393–401.
24] E. Antonini, M.  Brunori, Hemoglobin, Annu. Rev. Biochem. 39 (1970)
977–1042.
25] H. Smith, E.B. Mann, R. Motterlini, R.K. Poole, The carbon monoxide-releasing
molecule, CORM-3 (Ru(CO) 3Cl(glycinate)), targets respiration and oxidases in
campylobacter jejuni, generating hydrogen peroxide, IUBMB Life 63 (5)
(2011) 363–371.
26] J. Kim, A.R. Vaughn, C. Cho, T.V. Albu, E.A. Carver, Modiﬁcations of
ribonuclease A induced by p-benzoquinone, Bioorg. Chem. 40 (2012) 92–98.
27] P. Yu, I. Strug, T.R. Cafarella, B.A. Seaton, A. Krantz, Site-speciﬁc crosslinking of
annexin proteins by 1,4-benzoquinone: a novel crosslinker for the formation
of  protein dimers and diverse protein conjugates, Org. Biomol. Chem. 10
(2012) (2012) 4500–4504.28] R. Schneider, A. Mayer, W.  Schmatz, J. Schelten, R. Franzel, H. Eicher, X-ray
and  neutron small-angle scattering from hemoglobin in aqueous solution and
in  crystal, Eur. J. Biochem. 20 (1971) 179–182.
29] A.K. Mandal, M.R. Ramasamy, V. Sabareesh, M.E. Openshaw, K.S. Krishnan, P.
Balaram, Sequencing of T-superfamily conotoxins from Conus virgo:
gy Rep
[
[31] F.B. Pipkin, Genetics of preeclampsia consortium. Smoking inA. Ghosh et al. / Toxicolo
pyroglutamic acid identiﬁcation and disulﬁde arrangement by MALDI mass
spectrometry, J. Am.  Soc. Mass Spectrom. 18 (2007) 1396–1404.
30] X. Wang, B. Thomas, R. Sachdeva, L. Arterburn, L. Frye, P.G. Hatcher, D.G.
Cornwell, J. Ma,  Mechanism of arylating quinone toxicity involving Michael
adduct formation and induction of endoplasmic reticulum stress, Proc. Natl.
Acad. Sci. U. S. A. 103 (2006) 3604–3609.
[orts 3 (2016) 295–305 305moderate/severe preeclampsia worsens pregnancy outcome, but smoking
cessation limits the damage, Hypertension 51 (2008) 1042–1046.
32] L. Townsend, R.L. Maynard, Effects on health of prolonged exposure to low
concentrations of carbon monoxide, Occup. Environ. Med. 59 (2002) 708–711.
